Delivery Order SPE2DR25D6028-SPE2DR26FASCA
- Not listed
- The Defense Logistics Agency awarded a $18,039.22 delivery order to AmerisourceBergen Drug Corp for Menveo vaccine (5-pack) on November 4, 2025, with completion expected by November 5, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger prime...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,290.30 on September 25, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- The Defense Logistics Agency awarded a $31,213.44 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo vaccine on November 24, 2025, with completion expected by November 25, 2025. This competitively awarded, firm fixed-price contract was executed with no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $184,782 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML vaccine product. The order is scheduled for completion by October 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a small component of AmerisourceBergen's extensive pharmaceutical distribution services to federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Menveo vaccine (5-dose vials) with a ceiling value of $33,937.18. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025....
- The Defense Logistics Agency awarded a $53,326.80 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Menveo vaccine (5-dose vials) with an ultimate completion date of November 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $45,143 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135) in 0.5ML format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $12,746.62 delivery order to AmerisourceBergen Drug Corp for Menveo vaccine (5-dose vials) on December 1, 2025, with completion targeted for December 2, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's substantial $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs...
- The Defense Logistics Agency awarded a $6,502.80 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 3, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No small business set-aside was utilized for this procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a $326,442.90 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccines, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASCADelivery Order
The Defense Logistics Agency awarded a $7,478.22 delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Menveo vaccine (5-dose vials). This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of November 26, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026, which authorizes the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare procurement. The company maintains an extensive portfolio of competitively awarded delivery orders with the DLA covering diverse pharmaceutical products including vaccines, specialty medications, and medical supplies across multiple therapeutic domains. The firm fixed pricing model and consistent pattern of competitive awards reflect AmerisourceBergen's established capability to meet federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 11/24/25 |